Kevin Heal
Stock Analyst at Argus Research
(3.31)
# 947
Out of 4,749 analysts
46
Total ratings
67.74%
Success rate
9.96%
Average return
Main Sectors:
Stocks Rated by Kevin Heal
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NDAQ Nasdaq | Maintains: Buy | $76 → $82 | $82.28 | -0.34% | 4 | Nov 5, 2024 | |
RF Regions Financial | Upgrades: Buy | $26 | $24.77 | +4.97% | 2 | Oct 24, 2024 | |
ZION Zions Bancorporation, National Association | Downgrades: Hold | n/a | $58.29 | - | 2 | Jul 25, 2024 | |
HBAN Huntington Bancshares | Maintains: Buy | $15 → $16 | $17.39 | -7.99% | 3 | Jul 22, 2024 | |
MET MetLife | Maintains: Buy | $77 → $80 | $87.00 | -8.05% | 2 | May 22, 2024 | |
ICE Intercontinental Exchange | Reiterates: Buy | $153 | $159.44 | -4.04% | 5 | May 21, 2024 | |
AMP Ameriprise Financial | Maintains: Buy | $440 → $460 | $547.84 | -16.03% | 1 | May 6, 2024 | |
CFG Citizens Financial Group | Maintains: Buy | $36 → $39 | $48.36 | -19.35% | 5 | Apr 24, 2024 | |
CME CME Group | Maintains: Buy | $225 → $245 | $235.92 | +3.85% | 2 | Mar 6, 2024 | |
RITM Rithm Capital | Maintains: Buy | $11 → $12 | $11.56 | +3.81% | 1 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.36 | - | 3 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $205.91 | - | 5 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $12.84 | - | 3 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $20.47 | - | 1 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.08 | - | 1 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.35 | - | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $193.83 | - | 2 | May 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $185 | $274.78 | -32.67% | 2 | Jul 30, 2021 |
Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76 → $82
Current: $82.28
Upside: -0.34%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $24.77
Upside: +4.97%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $58.29
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15 → $16
Current: $17.39
Upside: -7.99%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77 → $80
Current: $87.00
Upside: -8.05%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $159.44
Upside: -4.04%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440 → $460
Current: $547.84
Upside: -16.03%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36 → $39
Current: $48.36
Upside: -19.35%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225 → $245
Current: $235.92
Upside: +3.85%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11 → $12
Current: $11.56
Upside: +3.81%
Jan 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $67.36
Upside: -
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $205.91
Upside: -
May 22, 2023
Upgrades: Hold
Price Target: n/a
Current: $12.84
Upside: -
Feb 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $20.47
Upside: -
Feb 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $10.08
Upside: -
Jun 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.35
Upside: -
May 20, 2022
Downgrades: Hold
Price Target: n/a
Current: $193.83
Upside: -
Jul 30, 2021
Upgrades: Buy
Price Target: $185
Current: $274.78
Upside: -32.67%